IRTC iRhythm Holdings, Inc.

CIK 0001388658 22 ready 8-Ks latest April 30, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 1 baseline Risk accumulating: auditor change (2), risk events (2)

Ready 8-Ks 22

Latest filing May 28, 2026, 7:33 AM ET

Top materiality 0.85

Event mix other_material ×9 · earnings ×9 · leadership ×2

Sentiment 11 pos · 1 neg · 10 neu

Latest earnings reported 2026-Q1

Executive change recent →

Recent 8-K filings for IRTC

Highest-materiality recent filing

iRhythm posts Q4 net income of $5.6M; first positive GAAP quarter; revenue +27% YoY; guides FY26 rev $870-880M

February 19, 2026, 6:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

Q4 revenue $208.9M (+27.1% YoY); GAAP net income $5.6M ($0.17 diluted EPS), first positive quarterly net income in company history.
Full year 2025 revenue $747.1M (+26.2%); net loss improved to $44.6M from $113.3M; first positive free cash flow of $34.5M.

Read filing →

April 30, 2026, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01 ◈ Earnings Releases

iRhythm Q1 revenue $199.4M (+25.7%), net loss narrows; raises FY2026 outlook

Revenue of $199.4M, up 25.7% YoY; net loss $13.9M ($0.43/sh) vs $30.7M ($0.97/sh) in Q1 2025.
February 19, 2026, 6:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

iRhythm posts Q4 net income of $5.6M; first positive GAAP quarter; revenue +27% YoY; guides FY26 rev $870-880M

Q4 revenue $208.9M (+27.1% YoY); GAAP net income $5.6M ($0.17 diluted EPS), first positive quarterly net income in company history.
October 30, 2025, 7:59 PM ET earnings materiality 0.75 positive item 1.01 item 5.02 item 2.02 item 9.01

iRhythm Q3 beat: rev $192.9M up 31% YoY, net loss narrows to $5.2M; FY25 guidance raised

Revenue $192.9M, up 30.7% YoY; gross margin 71.1% (+230bps).
July 31, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

iRhythm Q2 revenue up 26.1% to $186.7M; net loss narrows to $14.2M; raises FY 2025 guidance

Revenue $186.7M (+26.1% YoY); gross margin 71.2% (+130 bps).
May 1, 2025, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

iRhythm Q1 revenue up 20% to $158.7M; raises FY 2025 guidance

Revenue $158.7M (+20.3% YoY); gross margin 68.8% (+250 bps).
February 20, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

iRhythm Q4 revenue up 24% to $164.3M; net loss narrows to $1.3M; guides FY2025 revenue $675-685M

Q4 revenue $164.3M (+24% YoY); gross margin 70.0% (+410bps). Net loss $1.3M vs $38.7M loss in Q4 2023.
January 13, 2025, 6:59 PM ET other material materiality 0.70 positive item 7.01 item 9.01

iRhythm pre-announces FY2024 revenue above guidance; FY2025 outlook $675M-$685M

FY2024 revenue expected slightly above prior guidance of $587.5M (provided Oct 2024).
October 30, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

iRhythm Q3 revenue $147.5M (+18% YoY); gross margin 68.8% up 260 bps

Revenue $147.5M, up 18% YoY; gross profit $101.5M (+23%); gross margin 68.8% vs 66.2%
September 4, 2024, 7:59 PM ET other material materiality 0.70 positive item 1.01 item 7.01 item 9.01

iRhythm licenses BioIntelliSense sensor tech for up to $35M + royalties; reaffirms FY2024 guidance

iRhythm pays $15M upfront and up to $20M in milestone payments for an exclusive ACM license of pulse oximetry, accelerometry, and non-invasive BP tech.
August 1, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 5.02 item 7.01 item 9.01 ◈ executive_change ×2

iRhythm Q2 revenue $148M (+19.3% YoY), raises FY24 guidance; names new CFO

Revenue of $148.0M, up 19.3% YoY; gross margin 69.9% (+40 bps YoY).
May 2, 2024, 7:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01 ◈ Earnings Releases

iRhythm Q1 revenue $131.9M (+18.4% YoY); net loss widens to $45.7M; raises FY revenue guidance to $578-588M

Revenue $131.9M (+18.4% YoY); gross margin 66.3% (down 160 bps YoY).

Executive changes

Departed

Mojdeh Poul

Director

IRTC · iRhythm Holdings, Inc.

Filed: January 27, 2025, 6:59 PM ET

On January 23, 2025, Mojdeh Poul notified iRhythm Technologies, Inc. (the “Company”) of her decision to not seek re-election to the Board of Directors of the Company (the “Board”) at the expiration of her current term, which term ends on the date of the Company’s next annual meeting of stockholders.

Role change

Daniel Wilson

Chief Financial Officer

IRTC · iRhythm Holdings, Inc.

Effective: 2024-08-31
Filed: August 1, 2024, 7:59 PM ET

On July 31, 2024, the Board of Directors (the “Board”) of the Company appointed Daniel Wilson as the Company’s Chief Financial Officer and principal financial officer, effective as of August 31, 2024.

Departed

Brice Bobzien

Chief Financial Officer

IRTC · iRhythm Holdings, Inc.

Effective: 2024-08-31
Successor: Daniel Wilson
Filed: August 1, 2024, 7:59 PM ET

On August 1, 2024, iRhythm Technologies, Inc. (the “Company”) announced that Brice Bobzien resigned from his position as Chief Financial Officer of the Company, and his employment with the Company, effective August 31, 2024 (the “Separation Date”).

Earnings & guidance

2026-Q1 EPS reported -$0.43 filing →

Materiality & sentiment trend

Max materiality 0.85 · Median 0.60 · Most common event other_material

11 positive 1 negative 10 neutral

source · IRTC on sec.gov